
Ben S. Michelson
Examiner (ID: 6073, Phone: (571)270-1164 , Office: P/1625 )
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1625 |
| Total Applications | 286 |
| Issued Applications | 177 |
| Pending Applications | 1 |
| Abandoned Applications | 111 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8990602
[patent_doc_number] => 20130217883
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-22
[patent_title] => 'METHODS OF PRODUCING SULFILIMINE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/768543
[patent_app_country] => US
[patent_app_date] => 2013-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4681
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13768543
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/768543 | Methods of producing sulfilimine compounds | Feb 14, 2013 | Issued |
Array
(
[id] => 8977663
[patent_doc_number] => 20130211093
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-15
[patent_title] => 'Process for the Preparation of 1-Hydroxy-6-Substituted Pyridones'
[patent_app_type] => utility
[patent_app_number] => 13/763328
[patent_app_country] => US
[patent_app_date] => 2013-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4720
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13763328
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/763328 | Process for the preparation of 1-hydroxy-6-substituted pyridones | Feb 7, 2013 | Issued |
Array
(
[id] => 8866704
[patent_doc_number] => 20130150408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-13
[patent_title] => 'SUBSTITUTED DIOXOPIPERIDINYL PHTHALIMIDE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 13/762060
[patent_app_country] => US
[patent_app_date] => 2013-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10260
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13762060
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/762060 | SUBSTITUTED DIOXOPIPERIDINYL PHTHALIMIDE DERIVATIVES | Feb 6, 2013 | Abandoned |
Array
(
[id] => 8854386
[patent_doc_number] => 20130144061
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-06
[patent_title] => 'PROCESS FOR PREPARING A COMPOUND BY A NOVEL SANDMEYER-LIKE REACTION USING A NITROXIDE RADICAL COMPOUND AS A REACTION CATALYST'
[patent_app_type] => utility
[patent_app_number] => 13/756939
[patent_app_country] => US
[patent_app_date] => 2013-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19489
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13756939
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/756939 | Process for preparing a compound by a novel sandmeyer-like reaction using a nitroxide radical compound as a reaction catalyst | Jan 31, 2013 | Issued |
Array
(
[id] => 8951453
[patent_doc_number] => 20130197234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-01
[patent_title] => 'METHOD FOR PRODUCING OPTICALLY ACTIVE AMINE COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 13/757395
[patent_app_country] => US
[patent_app_date] => 2013-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19047
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13757395
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/757395 | METHOD FOR PRODUCING OPTICALLY ACTIVE AMINE COMPOUND | Jan 31, 2013 | Abandoned |
Array
(
[id] => 9631759
[patent_doc_number] => 20140209867
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-31
[patent_title] => 'Sulfonyl Group-Contained Compound and Organic Electroluminescent Device Using Sulfonyl Group-Contained Compound and Preparation Method Thereof'
[patent_app_type] => utility
[patent_app_number] => 13/823751
[patent_app_country] => US
[patent_app_date] => 2013-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5149
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13823751
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/823751 | Sulfonyl Group-Contained Compound and Organic Electroluminescent Device Using Sulfonyl Group-Contained Compound and Preparation Method Thereof | Jan 28, 2013 | |
Array
(
[id] => 10947013
[patent_doc_number] => 20140350034
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-27
[patent_title] => 'Aminopyridine derivatives as plasma kallikrein inhibitors'
[patent_app_type] => utility
[patent_app_number] => 14/371458
[patent_app_country] => US
[patent_app_date] => 2013-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13828
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14371458
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/371458 | Aminopyridine derivatives as plasma kallikrein inhibitors | Jan 24, 2013 | Abandoned |
Array
(
[id] => 10628639
[patent_doc_number] => 09346785
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-24
[patent_title] => 'Process for making HCV protease inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/739174
[patent_app_country] => US
[patent_app_date] => 2013-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5438
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13739174
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/739174 | Process for making HCV protease inhibitors | Jan 10, 2013 | Issued |
Array
(
[id] => 10050742
[patent_doc_number] => 09090608
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-28
[patent_title] => 'Pharmaceutical composition for preventing or treating osteoporosis or obesity comprising phenyltetrazole derivative'
[patent_app_type] => utility
[patent_app_number] => 13/734348
[patent_app_country] => US
[patent_app_date] => 2013-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10596
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13734348
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/734348 | Pharmaceutical composition for preventing or treating osteoporosis or obesity comprising phenyltetrazole derivative | Jan 3, 2013 | Issued |
Array
(
[id] => 8822450
[patent_doc_number] => 20130123495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-16
[patent_title] => 'HALOGEN-CONTAINING PERYLENETETRACARBOXYLIC ACID DERIVATIVES AND THE USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/734460
[patent_app_country] => US
[patent_app_date] => 2013-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18368
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13734460
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/734460 | Halogen-containing perylenetetracarboxylic acid derivatives and the use thereof | Jan 3, 2013 | Issued |
Array
(
[id] => 8892473
[patent_doc_number] => 20130165657
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-27
[patent_title] => 'PROCESS FOR PREPARATION OF OPTICALLY ACTIVE DIAMINE DERIVATIVE SALT'
[patent_app_type] => utility
[patent_app_number] => 13/732857
[patent_app_country] => US
[patent_app_date] => 2013-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13612
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13732857
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/732857 | Process for preparation of optically active diamine derivative salt | Jan 1, 2013 | Issued |
Array
(
[id] => 10226936
[patent_doc_number] => 20150111929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-23
[patent_title] => 'PROCESS FOR PREPARING CRYSTALLINE SORAFENIB TOSYLATE'
[patent_app_type] => utility
[patent_app_number] => 14/381226
[patent_app_country] => US
[patent_app_date] => 2012-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4563
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14381226
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/381226 | PROCESS FOR PREPARING CRYSTALLINE SORAFENIB TOSYLATE | Dec 30, 2012 | Abandoned |
Array
(
[id] => 10946952
[patent_doc_number] => 20140349973
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-27
[patent_title] => 'METALLOENZYME INHIBITOR COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 14/364276
[patent_app_country] => US
[patent_app_date] => 2012-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44175
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14364276
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/364276 | Metalloenzyme inhibitor compounds | Dec 9, 2012 | Issued |
Array
(
[id] => 8866705
[patent_doc_number] => 20130150407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-13
[patent_title] => 'PIPERIDINYL NAPHTHYLACETIC ACIDS'
[patent_app_type] => utility
[patent_app_number] => 13/706497
[patent_app_country] => US
[patent_app_date] => 2012-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32070
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13706497
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/706497 | Piperidinyl naphthylacetic acids | Dec 5, 2012 | Issued |
Array
(
[id] => 8854382
[patent_doc_number] => 20130144057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-06
[patent_title] => '(METH)ACRYLIC ACID ESTER, ACTIVATION ENERGY RAY CURING COMPOSITION, AND INKJET RECORDING INK'
[patent_app_type] => utility
[patent_app_number] => 13/687224
[patent_app_country] => US
[patent_app_date] => 2012-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13345
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13687224
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/687224 | (Meth)acrylic acid ester, activation energy ray curing composition, and inkjet recording ink | Nov 27, 2012 | Issued |
Array
(
[id] => 9205011
[patent_doc_number] => 20140004188
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-02
[patent_title] => 'CRYSTAL FORMS OF (R)-N-METHYLNALTREXONE BROMIDE AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/682878
[patent_app_country] => US
[patent_app_date] => 2012-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 15222
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13682878
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/682878 | Crystal forms of (R)-N-methylnaltrexone bromide and uses thereof | Nov 20, 2012 | Issued |
Array
(
[id] => 9692093
[patent_doc_number] => 08822688
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-02
[patent_title] => 'Imidazo[1,2-a]pyridine derivative'
[patent_app_type] => utility
[patent_app_number] => 13/661601
[patent_app_country] => US
[patent_app_date] => 2012-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13303
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13661601
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/661601 | Imidazo[1,2-a]pyridine derivative | Oct 25, 2012 | Issued |
Array
(
[id] => 8660325
[patent_doc_number] => 20130041154
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-14
[patent_title] => 'PROCESS FOR PRODUCING CISATRACURIUM AND ASSOCIATED INTERMEDIATES'
[patent_app_type] => utility
[patent_app_number] => 13/648830
[patent_app_country] => US
[patent_app_date] => 2012-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7481
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13648830
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/648830 | PROCESS FOR PRODUCING CISATRACURIUM AND ASSOCIATED INTERMEDIATES | Oct 9, 2012 | Abandoned |
Array
(
[id] => 9108566
[patent_doc_number] => 20130281698
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-24
[patent_title] => 'Novel 6-Amino-Morphinan Derivatives, Method of Manufacturing Them and Their Application as Analgesics'
[patent_app_type] => utility
[patent_app_number] => 13/648033
[patent_app_country] => US
[patent_app_date] => 2012-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 38452
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13648033
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/648033 | Novel 6-Amino-Morphinan Derivatives, Method of Manufacturing Them and Their Application as Analgesics | Oct 8, 2012 | Abandoned |
Array
(
[id] => 8638378
[patent_doc_number] => 20130030182
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-31
[patent_title] => 'METHODS FOR THE SYNTHESIS OF TIOTROPIUM BROMIDE'
[patent_app_type] => utility
[patent_app_number] => 13/632593
[patent_app_country] => US
[patent_app_date] => 2012-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7721
[patent_no_of_claims] => 95
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13632593
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/632593 | Methods for the synthesis of tiotropium bromide | Sep 30, 2012 | Issued |